The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scrip Dividend

17 Jul 2018 09:00

RNS Number : 8617U
Stenprop Limited
17 July 2018
 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

FINALISATION ANNOUNCEMENT IN RESPECT OF AN ELECTION TO RECEIVE

EITHER A CASH DIVIDEND OR A SCRIP DIVIDEND

 

17 July 2018

 

Stenprop shareholders are referred to the circular and the announcement issued on Tuesday, 10 July 2018 in respect of an election to receive the final dividend for the six months ended 31 March 2018, either as a cash dividend (the "cash dividend") or as a scrip dividend (the "scrip dividend") and are advised that the salient dates as announced on 10 July 2018 remain unchanged. Shareholders are further advised as follows:

 

- Shareholders holding shares traded on the JSE will receive their cash dividend in South African Rand ("ZAR" or "Rand") converted from Great British Pound ("GBP" or "Sterling") at an exchange rate of GBP 1.00:ZAR 17.5046 determined on Tuesday, 17 July 2018 ("Sterling exchange rate"). Accordingly, the cash dividend of 4.00 pence per share will be equal to approximately ZAR 0.70 per share.

 

- The scrip dividend reference price is GBP 1.1330 ("scrip dividend reference price"), being the average closing price of Stenprop shares traded on the London Stock Exchange ("LSE") over a period of five days as at Friday, 13 July 2018 less the amount of the cash dividend. For Stenprop shares on the South African share register, the scrip dividend reference price will be converted to Rand at the Sterling exchange rate.

 

- Shareholders electing to receive the scrip dividend will receive approximately 3.53 new Stenprop shares for every 100 Stenprop shares already held by such shareholders on the record date of Friday, 27 July 2018, representing the ratio that the cash dividend bears to the scrip dividend reference price.

 

- The allocation of new Stenprop shares will be such that shareholders who elect to receive the scrip dividend will not be allocated a fraction of a new Stenprop share. Any entitlement to receive a fraction of a new Stenprop share will be rounded down to the nearest whole number, with a cash payment ("cash payment") made to the relevant shareholder in respect of the fraction. The value of a Stenprop share to be utilised in determining the cash payment due to shareholders is equal to the scrip dividend reference price. On this basis, shareholders are advised that the gross value of a Stenprop share to be utilised in determining the cash payment due to shareholders is GBP1.1330 for shareholders on the Guernsey share register. For shareholders on the SA share register, this gross value is approximately ZAR 19.8327, being the Sterling value referred to above converted to Rand at the conversion rate of GBP 1.00:ZAR 17.5046.

 

If no shareholders were to elect to receive the scrip dividend, the value of the dividends would amount to GBP 11,309,724.24. Should all shareholders elect to receive the scrip dividend, the maximum total number of new Stenprop shares to be issued by Stenprop pursuant to the scrip dividend will be 9,982,104.

The share capital of the company as at the date of this announcement is as follows:

 

EUR

Share capital

Authorised share capital

1,000,000,000 ordinary shares with a par value of EUR 0.000001258 each

1,258

Issued share capital

291,769,295 ordinary shares with a par value of EUR 0.000001258 each

367

 

Should all eligible Stenprop shareholders elect to receive the scrip dividend, the share capital of Stenprop after issue of the new Stenprop shares will be as follows:

 

EUR

Share capital

Authorised share capital

1,000,000,000 ordinary shares with a par value of EUR 0.000001258 each

1,258

Issued share capital

301,751,399 ordinary shares with a par value of EUR 0.000001258 each

380

 

The receipt of a cash payment may have tax implications for shareholders. For South African resident shareholders, such amount may be regarded as a foreign dividend and, if it is, may be subject to South African dividends withholding tax at a rate of 20%, unless an exemption as set out in South African Income Tax legislation applies. For South African resident shareholders liable to pay dividends withholding tax at the rate of 20%, the net local dividend amount is ZAR 0.5601 per share. There is currently no withholding tax on ordinary dividends for UK resident shareholders. All shareholders are referred to the general summary of certain limited aspects of the taxation treatment of cash dividend which is included in the circular.

 

 

Enquiries:

 

Stenprop Limited

Paul ArensonPatsy WatsonJulian Carey

+44(0)20 7079 6600

 

Numis Securities Limited (Financial Adviser)

Hugh JonathanVicki Paine

+44(0)20 7260 1000

 

Tavistock (PR adviser)

James Whitmore

James Verstringhe

Kirsty Allan

+44(0)20 7920 3150

Instinctif Partners (SA Investor Relations and PR Adviser)

+27 (0)11 447 3030

Keagile Makgoba

 

 

Java Capital Trustees and Sponsors Proprietary Limited (JSE Sponsor)

 

+ 27 (0) 11 722 3050

 

 

About Stenprop

 

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial ("MLI") properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 

Stenprop has a listing on the Specialist Fund Segment of the main market of the LSE and a primary listing on the Main Board of the JSE.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVRRMRTMBABMAP
Date   Source Headline
14th Sep 20219:30 amRNSInvestor Tour
14th Sep 20217:09 amRNSInvestor Tour
13th Sep 20219:00 amRNSResult of AGM
8th Sep 202110:12 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSGuernsey office sale takes portfolio to 92% MLI
26th Aug 20217:00 amRNSStenprop completes £15.9m double acquisition
12th Aug 20219:00 amRNSResult Of Election For Cash Or Scrip Dividend
6th Aug 202112:00 pmRNSChange To The Total Number Of Voting Rights
6th Aug 20217:00 amRNSCompletion of EUR30.8M Berlin shopping centre sale
3rd Aug 20213:00 pmRNSDirector/PDMR Shareholding
3rd Aug 202112:00 pmRNSHolding(s) in Company
30th Jul 20217:00 amRNSTrading Statement and Rent Collection Update
29th Jul 20212:00 pmRNSPosting Of Notice Of Annual General Meeting
15th Jul 20218:00 amRNSDealings By A Director Of The Company
13th Jul 20219:00 amRNSFinalisation Announcement In Respect Of Election
7th Jul 20213:00 pmRNSChange to the total number of voting rights
7th Jul 20217:00 amRNSStenprop completes £20.6 million Wigan acquisition
6th Jul 20213:00 pmRNSChange to the total number of voting rights
2nd Jul 20212:00 pmRNSScrip Dividend Circular
28th Jun 20212:00 pmRNSChange to the Total number of Voting Rights
24th Jun 20213:00 pmRNSNo Change Statement/ Publication Of Annual Report
22nd Jun 20219:00 amRNSChange to the total number of voting rights
15th Jun 202112:00 pmRNSDirector/PDMR Shareholding
11th Jun 20217:00 amRNSPreliminary results for year ended 31 March 2021
24th May 20219:00 amRNSNotice of Full Year Results
30th Apr 20217:00 amRNSMLI Trading Update Q4 FY21
1st Apr 20217:00 amRNSCompletion of MLI Acquisition & Retail Asset Sales
30th Mar 20219:00 amRNSDirector/PDMR Shareholding
22nd Mar 202110:00 amRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNSAcquisition of three multi-let industrial estates
24th Feb 202110:30 amRNSDirector/PDMR Shareholding
16th Feb 20219:00 amRNSDirector/PDMR Shareholding
11th Feb 202111:00 amRNSResult of election for cash or scrip dividend
9th Feb 202111:00 amRNSTransaction in Own Shares
2nd Feb 20213:00 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSMLI Trading Update
22nd Jan 20217:00 amRNSNotice of Quarterly Trading Update
12th Jan 20219:00 amRNSScrip Dividend Circular
7th Jan 202111:00 amRNSDirector/PDMR Shareholding
29th Dec 20207:00 amRNSDisposal of Berlin Shopping Centre for EUR30.8M
22nd Dec 20207:00 amRNSAcquisition of three multi-let industrial estates
21st Dec 20207:00 amRNSDisposal of Victoria Retail Centre for EUR37.45M
17th Dec 20202:00 pmRNSScrip Dividend Circular
15th Dec 20207:00 amRNSStenprop secures new £66.5m debt facility
14th Dec 20202:00 pmRNSDirector/PDMR Shareholding
4th Dec 20207:01 amRNSSummarised Half Year Results
4th Dec 20207:00 amRNSHalf Year Results
2nd Dec 20203:30 pmRNSChanges to the board committees
16th Nov 20209:00 amRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.